Cuadrado et al., 2018 - Google Patents
Microenvironment eradication of hepatitis C: a novel treatment paradigmCuadrado et al., 2018
- Document ID
- 6332198560351490397
- Author
- Cuadrado A
- Llerena S
- Cobo C
- Pallás J
- Mateo M
- Cabezas J
- Fortea J
- Alvarez S
- Pellón R
- Crespo J
- Echevarría S
- Ayesa R
- Setién E
- Lopez-Hoyos M
- Crespo-Facorro B
- Agüero J
- Chueca N
- Garcia F
- Calleja J
- Crespo J
- Publication year
- Publication venue
- Official journal of the American College of Gastroenterology| ACG
External Links
Snippet
OBJECTIVES: Prisons are major reservoirs of hepatitis C virus (HCV) in which a therapeutic approach has been particularly difficult so far. Our aim was to create a permanent program of HCV elimination in a prison based on a “test and treat” strategy. METHODS: This open …
- 208000005176 Hepatitis C 0 title description 13
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/10—Office automation, e.g. computer aided management of electronic mail or groupware; Time management, e.g. calendars, reminders, meetings or time accounting
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F3/00—Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
- G06F3/01—Input arrangements or combined input and output arrangements for interaction between user and computer
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/01—Social networking
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F2221/00—Indexing scheme relating to security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cuadrado et al. | Microenvironment eradication of hepatitis C: a novel treatment paradigm | |
Afdhal et al. | The new paradigm of hepatitis C therapy: integration of oral therapies into best practices | |
Dore et al. | Elbasvir–grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy: a randomized trial | |
Masson et al. | A randomized trial of a hepatitis care coordination model in methadone maintenance treatment | |
Martinello et al. | HCV reinfection incidence among individuals treated for recent infection | |
Sorrell et al. | National Institutes of Health consensus development conference statement: management of hepatitis B | |
Armstrong et al. | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | |
Saeed et al. | Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada | |
Spradling et al. | Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996–2007 | |
Kahler et al. | Direct and indirect effects of heavy alcohol use on clinical outcomes in a longitudinal study of HIV patients on ART | |
Ward et al. | A randomized controlled trial of cash incentives or peer support to increase HCV treatment for persons with HIV who use drugs: the CHAMPS study | |
Zeremski et al. | Hepatitis C virus–related knowledge and willingness to receive treatment among patients on methadone maintenance | |
Sears et al. | Birth cohort screening for chronic hepatitis during colonoscopy appointments | |
Kugelmas et al. | Hepatitis C point-of-care screening in retail pharmacies in the United States | |
Ford et al. | Check Hep C: a community-based approach to hepatitis C diagnosis and linkage to care in high-risk populations | |
Schmidbauer et al. | Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs—first real world data from Austria | |
Hagins et al. | Switching to bictegravir/emtricitabine/tenofovir alafenamide in black Americans with HIV-1: a randomized phase 3b, multicenter, open-label study | |
Trabut et al. | Integrated care for the use of direct-acting antivirals in patients with chronic hepatitis C and substance use disorder | |
Zeremski et al. | Improvements in HCV-related knowledge among substance users on opioid agonist therapy after an educational intervention | |
Re III et al. | Determinants of liver complications among HIV/hepatitis B virus–coinfected patients | |
Ragni et al. | Liver transplant outcomes in HIV (+) haemophilic men | |
Starbird et al. | Nurse case management to improve the hepatitis C care continuum in HIV co‐infection: Results of a randomized controlled trial | |
Childs-Kean et al. | Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C | |
Sarrazin et al. | Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal | |
Anand | Hepatitis C virus in India: challenges and successes |